Cargando…
Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
Computational design of small molecule putative inhibitors of Polo-like kinase 1 (Plk1) is presented. Plk1, which regulates the cell cycle, is often over expressed in cancers. Down regulation of Plk1 has been shown to inhibit tumor progression. Most kinase inhibitors interact with the ATP binding si...
Autores principales: | Jani, Krupa S., Dalafave, D.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290105/ https://www.ncbi.nlm.nih.gov/pubmed/22399850 http://dx.doi.org/10.4137/BBI.S8971 |
Ejemplares similares
-
Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012) -
Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022) -
Targeting Echinococcus multilocularis Stem Cells by Inhibition of the Polo-Like Kinase EmPlk1
por: Schubert, Andreas, et al.
Publicado: (2014) -
Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
por: Colicino, Erica G., et al.
Publicado: (2018) -
PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
por: Ruf, Stefanie, et al.
Publicado: (2017)